Fingerpaint Group Adds Market Access Veteran Wyatt Gotbetter as President
Event summary
- Fingerpaint Group appointed Wyatt Gotbetter as president of market access on September 22, 2026.
- Gotbetter brings nearly 30 years of experience in new-product commercialization, payer strategy, health economics, and real-world evidence.
- He will lead Fingerpaint Market Access, The MYND Group, and BlackPoint Consulting Group.
- Gotbetter previously served as global head of evidence, value, and access at Cytel and senior vice president at Parexel.
The big picture
Fingerpaint Group's appointment of Wyatt Gotbetter underscores the growing importance of integrated market access capabilities in the life sciences sector. As pharmaceutical companies increasingly seek end-to-end solutions for product development and commercialization, Fingerpaint's move positions it to compete more effectively against larger consultancies. The hire also highlights the trend towards combining strategic consulting with operational execution to meet client needs across all stages of a product launch.
What we're watching
- Integration Strategy
- How Gotbetter will integrate strategic consulting, creative, and operational execution under one roof.
- Client Retention
- Whether Fingerpaint Group can sustain its industry-leading retention rate with this leadership change.
- Market Expansion
- The pace at which Fingerpaint Group can expand its market access capabilities globally.